BRIEF published on 07/05/2024 at 14:05, 8 months 29 days ago The Lifesciences Magazine Highlights Innovative Biopharma Company Targeting Diabetes in 2024 Innovation Diabetes Healthcare Treatment Biopharma
BRIEF published on 07/05/2024 at 14:05, 8 months 29 days ago Le magazine Lifesciences met en lumière une entreprise biopharmaceutique innovante ciblant le diabète en 2024 Innovation Biopharmaceutique Soins De Santé Traitement Diabète
PRESS RELEASE published on 07/05/2024 at 14:00, 8 months 29 days ago The Lifesciences Magazine's New Issue Features the Most Innovative Biopharma Company Targeting Diabetes in 2024 Lifesciences Magazine features Diabetology Limited, a leading biopharma company revolutionizing diabetes treatment. Exclusive interview with co-founder Glen Travers Innovation Diabetes Treatment Biopharma Lifesciences Magazine Diabetology Limited
Published on 04/03/2025 at 15:05, 8 hours 31 minutes ago Snowline Gold Closes Fully Subscribed C$20 Million Financing Of Flow-Through Shares
Published on 04/03/2025 at 15:00, 8 hours 36 minutes ago Kingstone Insurance Partners with Kyber Technologies Inc.
Published on 04/03/2025 at 15:00, 8 hours 36 minutes ago UniDoc Announces Debt Settlement and Renews Marketing Engagement
Published on 04/03/2025 at 15:00, 8 hours 36 minutes ago Xebra Brands’ Largest Shareholder Increases Stake as Company Explores Landmark Agricultural Agreement in Mexico
Published on 04/03/2025 at 14:30, 9 hours 6 minutes ago Dominari Holdings Highlights Supporting American Companies
Published on 04/03/2025 at 18:46, 4 hours 50 minutes ago Monthly disclosure of the total number of shares and voting rights - March 2025
Published on 04/03/2025 at 18:46, 4 hours 50 minutes ago Déclaration mensuelle des actions et droits de vote – Mars 2025
Published on 04/03/2025 at 18:00, 5 hours 36 minutes ago LDC : Chiffre d'affaires 2024-2025 : 6,3 milliards d’euros, au-delà des objectifs.
Published on 04/03/2025 at 17:45, 5 hours 51 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
